Literature DB >> 24696595

Oxidative damage in the progression of chronic liver disease to hepatocellular carcinoma: an intricate pathway.

Romilda Cardin1, Marika Piciocchi1, Marina Bortolami1, Andromachi Kotsafti1, Luisa Barzon1, Enrico Lavezzo1, Alessandro Sinigaglia1, Kryssia Isabel Rodriguez-Castro1, Massimo Rugge1, Fabio Farinati1.   

Abstract

The histo-pathologic and molecular mechanisms leading to initiation and progression of hepatocellular carcinoma (HCC) are still ill-defined; however, there is increasing evidence that the gradual accumulation of mutations, genetic and epigenetic changes which occur in preneoplastic hepatocytes results in the development of dysplastic foci, nodules, and finally, overt HCC. As well as many other neoplasias, liver cancer is considered an "inflammatory cancer", arising from a context of inflammation, and characterized by inflammation-related mechanisms that favor tumor cell survival, proliferation, and invasion. Molecular mechanisms that link inflammation and neoplasia have been widely investigated, and it has been well established that inflammatory cells recruited at these sites with ongoing inflammatory activity release chemokines that enhance the production of reactive oxygen species. The latter, in turn, probably have a major pathogenic role in the continuum starting from hepatitis followed by chronic inflammation, and ultimately leading to cancer. The relationship amongst chronic liver injury, free radical production, and development of HCC is explored in the present review, particularly in the light of the complex network that involves oxidative DNA damage, cytokine synthesis, telomere dysfunction, and microRNA regulation.

Entities:  

Keywords:  Antioxidant mechanisms; Cytokines; Hepatocellular carcinoma; MicroRNA and circulating free DNA; Reactive oxygen species; Telomere dysfunction; Viral hepatitis; mitochondria

Mesh:

Substances:

Year:  2014        PMID: 24696595      PMCID: PMC3964380          DOI: 10.3748/wjg.v20.i12.3078

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  74 in total

1.  Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1.

Authors:  Na Li; Senthilkumar Muthusamy; Ruqiang Liang; Harshini Sarojini; Eugenia Wang
Journal:  Mech Ageing Dev       Date:  2011-01-07       Impact factor: 5.432

2.  Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake.

Authors:  Marie-Pierre Lambert; Anupam Paliwal; Thomas Vaissière; Isabelle Chemin; Fabien Zoulim; Massimo Tommasino; Pierre Hainaut; Bakary Sylla; Jean-Yves Scoazec; Jörg Tost; Zdenko Herceg
Journal:  J Hepatol       Date:  2010-09-25       Impact factor: 25.083

3.  Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C.

Authors:  Eduardo Vilar Gomez; Yadina Martinez Perez; Hector Vega Sanchez; Gretel Riveron Forment; Enrique Arus Soler; Luis Calzadilla Bertot; Ali Yasells Garcia; Maria del Rosario Abreu Vazquez; Licet Gonzalez Fabian
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

4.  Oxidative damage, pro-inflammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis.

Authors:  Fabio Farinati; Romilda Cardin; Marina Bortolami; Maria Guido; Massimo Rugge
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

Review 5.  Human DNA glycosylases involved in the repair of oxidatively damaged DNA.

Authors:  Hiroshi Ide; Mitsuharu Kotera
Journal:  Biol Pharm Bull       Date:  2004-04       Impact factor: 2.233

6.  Dysregulation of DNA repair pathways in a transforming growth factor alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis.

Authors:  Koji Hironaka; Valentina M Factor; Diego F Calvisi; Elizabeth A Conner; Snorri S Thorgeirsson
Journal:  Lab Invest       Date:  2003-05       Impact factor: 5.662

Review 7.  Genetics and epigenetics of liver cancer.

Authors:  Cigdem Ozen; Gokhan Yildiz; Alper Tunga Dagcan; Dilek Cevik; Aysegul Ors; Umur Keles; Hande Topel; Mehmet Ozturk
Journal:  N Biotechnol       Date:  2013-02-04       Impact factor: 5.079

8.  TNF-alpha induced DNA damage in primary murine hepatocytes.

Authors:  Nicholas M Wheelhouse; Yuen-Sum Chan; Sheona E Gillies; Helen Caldwell; James A Ross; David J Harrison; Sandrine Prost
Journal:  Int J Mol Med       Date:  2003-12       Impact factor: 4.101

Review 9.  Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview.

Authors:  Monica Marra; Ignazio M Sordelli; Angela Lombardi; Monica Lamberti; Luciano Tarantino; Aldo Giudice; Paola Stiuso; Alberto Abbruzzese; Rossella Sperlongano; Marina Accardo; Massimo Agresti; Michele Caraglia; Pasquale Sperlongano
Journal:  J Transl Med       Date:  2011-10-10       Impact factor: 5.531

10.  Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma.

Authors:  Romilda Cardin; Cardin Romilda; Marika Piciocchi; Piciocchi Marika; Alessandro Sinigaglia; Sinigaglia Alessandro; Enrico Lavezzo; Lavezzo Enrico; Marina Bortolami; Bortolami Marina; Andromachi Kotsafti; Kotsafti Andromachi; Umberto Cillo; Cillo Umberto; Giacomo Zanus; Zanus Giacomo; Claudia Mescoli; Mescoli Claudia; Massimo Rugge; Rugge Massimo; Fabio Farinati; Farinati Fabio
Journal:  BMC Cancer       Date:  2012-05-15       Impact factor: 4.430

View more
  26 in total

1.  Gastric atrophy and xanthelasma are markers for predicting the development of early gastric cancer.

Authors:  Akira Sekikawa; Hirokazu Fukui; Ryota Sada; Manabu Fukuhara; Saiko Marui; Gensho Tanke; Masatsugu Endo; Yoshiaki Ohara; Fumihiro Matsuda; Jun Nakajima; Shinichiro Henmi; Sumio Saito; Takehiko Tsumura; Takanori Maruo; Toru Kimura; Yukio Osaki
Journal:  J Gastroenterol       Date:  2015-04-23       Impact factor: 7.527

Review 2.  Hepatocellular carcinoma and the risk of occupational exposure.

Authors:  Venerando Rapisarda; Carla Loreto; Michele Malaguarnera; Annalisa Ardiri; Maria Proiti; Giuseppe Rigano; Evelise Frazzetto; Maria Irene Ruggeri; Giulia Malaguarnera; Nicoletta Bertino; Mariano Malaguarnera; Vito Emanuele Catania; Isidoro Di Carlo; Adriana Toro; Emanuele Bertino; Dario Mangano; Gaetano Bertino
Journal:  World J Hepatol       Date:  2016-05-08

Review 3.  Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver disease.

Authors:  Francesco Paolo Russo; Kryssia Rodríguez-Castro; Laura Scribano; Giorgia Gottardo; Veronica Vanin; Fabio Farinati
Journal:  World J Hepatol       Date:  2015-05-18

4.  Simplified HCC-ART score for highly sensitive detection of small-sized and early-stage hepatocellular carcinoma in the widely used Okuda, CLIP, and BCLC staging systems.

Authors:  Abdelfattah M Attallah; Mohamed M Omran; Ahmed A Attallah; Mohamed A Abdelrazek; Khaled Farid; Ibrahim El-Dosoky
Journal:  Int J Clin Oncol       Date:  2016-11-18       Impact factor: 3.402

5.  Urinary biomarkers of catechins and risk of hepatocellular carcinoma in the Shanghai Cohort Study.

Authors:  Lesley M Butler; Joyce Yongxu Huang; Renwei Wang; Mao-Jun Lee; Chung S Yang; Yu-Tang Gao; Jian-Min Yuan
Journal:  Am J Epidemiol       Date:  2015-02-21       Impact factor: 4.897

6.  AMPK activation by liquiritigenin inhibited oxidative hepatic injury and mitochondrial dysfunction induced by nutrition deprivation as mediated with induction of farnesoid X receptor.

Authors:  Eun Hye Jung; Ju-Hee Lee; Sang Chan Kim; Young Woo Kim
Journal:  Eur J Nutr       Date:  2015-12-08       Impact factor: 5.614

Review 7.  Two Faces of Neutrophils in Liver Disease Development and Progression.

Authors:  Yeonhee Cho; Gyongyi Szabo
Journal:  Hepatology       Date:  2021-06-18       Impact factor: 17.298

8.  Status of Superoxide Dismutase in Transfusion Dependent Thalassaemia.

Authors:  Lantip Rujito; Sri Mulatsih; Abdul Salam M Sofro
Journal:  N Am J Med Sci       Date:  2015-05

9.  TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.

Authors:  Aitor Esparza-Baquer; Ibone Labiano; Omar Sharif; Aloña Agirre-Lizaso; Fiona Oakley; Pedro M Rodrigues; Ekaterina Zhuravleva; Colm J O'Rourke; Elizabeth Hijona; Raul Jimenez-Agüero; Ioana Riaño; Ana Landa; Adelaida La Casta; Marco Y W Zaki; Patricia Munoz-Garrido; Mikel Azkargorta; Felix Elortza; Andrea Vogel; Gernot Schabbauer; Patricia Aspichueta; Jesper B Andersen; Sylvia Knapp; Derek A Mann; Luis Bujanda; Jesus Maria Banales; Maria Jesus Perugorria
Journal:  Gut       Date:  2020-09-09       Impact factor: 23.059

Review 10.  Natural Polyphenols in Metabolic Syndrome: Protective Mechanisms and Clinical Applications.

Authors:  Shiyao Zhang; Mengyi Xu; Wenxiang Zhang; Chang Liu; Siyu Chen
Journal:  Int J Mol Sci       Date:  2021-06-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.